Correction
Correction: Replication of Genetic
Polymorphisms Reported to Be Associated
with Taxane-Related Sensory Neuropathy in
Patients with Early Breast Cancer Treated
with Paclitaxel—Letter
Clinical
Cancer
Research
In this letter (Clin Cancer Res 2015;21:3092–3), which was published in the July 1,
2015, issue of Clinical Cancer Research (1), the A/A and G/G labeling in each panel
of Fig. 1 is incorrect—the labels should be reversed. A corrected version of the figure is
shown below. The figure legend and main text remain unchanged. The error does not
affect the conclusions set forth in the letter. The authors regret this error.
EPHA5 rs7349683
% Patients free of neuropathy
1.0
EPHA8 rs209709
EPHA6 rs301927
1.0
1.0
G/G and G/A (n = 127)
A/A (n = 100)
A/G (n = 39)
G/G (n = 1)
A/A (n = 17)
0.8
0.8
HR = 2.3 (95% CI, 1.6–3.9)
Precessive=0.0074
0.6
HR = 1.9 (95% CI, 1.2–2.9)
Padditive=0.0063
0.6
0.8
0.4
0.4
0.2
0.2
0.2
0.0
0
1,000 2,000 3,000 4,000 5,000 6,000
Cumulative paclitaxel dose (mg)
HR = 1.9 (95% CI, 1.1–3.2)
Padditive=0.012
0.6
0.4
0.0
A/A (n = 116)
A/G (n = 27)
G/G (n = 1)
0.0
0
1,000 2,000 3,000 4,000 5,000 6,000
Cumulative paclitaxel dose (mg)
0
1,000 2,000 3,000 4,000 5,000 6,000
Cumulative paclitaxel dose (mg)
Figure 1.
Reference
1. Apellaniz-Ruiz M, Sanchez-Barroso L, Gutierrez-Gutierrez G, Sereno M, García-Donas J,
Åvall-Lundqvist E, et al. Replication of genetic polymorphisms reported to be associated
with taxane-related sensory neuropathy in patients with early breast cancer treated with
paclitaxel—letter. Clin Cancer Res 2015;21:3092–3.
Published online September 15, 2015.
doi: 10.1158/1078-0432.CCR-15-1693
Ó2015 American Association for Cancer Research.
4244 Clin Cancer Res; 21(18) September 15, 2015
Downloaded from clincancerres.aacrjournals.org on June 17, 2017. © 2015 American Association for Cancer Research.
Correction: Replication of Genetic Polymorphisms Reported to Be
Associated with Taxane-Related Sensory Neuropathy in Patients
with Early Breast Cancer Treated with Paclitaxel−−Letter
Clin Cancer Res 2015;21:4244.
Updated version
Cited articles
E-mail alerts
Reprints and
Subscriptions
Permissions
Access the most recent version of this article at:
http://clincancerres.aacrjournals.org/content/21/18/4244
This article cites 1 articles, 1 of which you can access for free at:
http://clincancerres.aacrjournals.org/content/21/18/4244.full.html#ref-list-1
Sign up to receive free email-alerts related to this article or journal.
To order reprints of this article or to subscribe to the journal, contact the AACR Publications Department at
[email protected].
To request permission to re-use all or part of this article, contact the AACR Publications Department at
[email protected].
Downloaded from clincancerres.aacrjournals.org on June 17, 2017. © 2015 American Association for Cancer Research.